Patents by Inventor Troy W. McCall

Troy W. McCall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE MATRIX SYSTEMS FOR HIGHLY SOLUBLE DRUGS
    Publication number: 20140242166
    Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.
    Type: Application
    Filed: March 3, 2014
    Publication date: August 28, 2014
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Anand R. Baichwal, Troy W McCALL, Lirong LlU, Steve LABUDZINSKI
  • Sustained release matrix systems for highly soluble drugs
    Patent number: 8679535
    Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: March 25, 2014
    Assignee: Endo Pharmaceuticals Inc.
    Inventors: Anand R. Baichwal, Troy W. McCall, Lirong Liu, Steve Labudzinski
  • Sustained release formulations of oxymorphone
    Patent number: 7276250
    Abstract: Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: October 2, 2007
    Assignee: Penwest Pharmaceuticals Company
    Inventors: Anand R. Baichwal, Huai-Hung Kao, Troy W. McCall
  • Sustained release matrix systems for highly soluble drugs
    Publication number: 20040170684
    Abstract: Disclosed are sustained release oral solid dosage forms comprising a therapeutically effective amount of a medicament having a solubility of more than about 10 g/l; a pH modifying agent; and a sustained release matrix comprising a gelling agent, said gelling agent comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum when exposed to an environmental fluid, said dosage form providing a sustained release of said medicament after oral administration to human patients.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 2, 2004
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Anand R. Baichwal, Troy W. McCall, Lirong Liu, Steve Labudzinski
  • Sustained release metoprolol formulations
    Publication number: 20030228361
    Abstract: The present invention relates to a sustained release oral dosage forms containing a therapeutically effective amount of metoprolol tartrate, methods of preparing such formulations, and to methods of treatment utilizing such formulations.
    Type: Application
    Filed: April 7, 2003
    Publication date: December 11, 2003
    Inventors: Anand R. Baichwal, Paul Woodcock, Pradeepkumar P. Sanghvi, Dean M. Dinicola, Troy W. McCall
  • Sustained release formulations of oxymorphone
    Publication number: 20030129230
    Abstract: Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: July 3, 2002
    Publication date: July 10, 2003
    Applicant: Penwest Pharmaceuticals Company
    Inventors: Anand R. Baichwal, Huai-Hung Kao, Troy W. McCall
  • Methods of making sustained release formulations of oxymorphone
    Publication number: 20030129234
    Abstract: Sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of oxymorphone or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: July 3, 2002
    Publication date: July 10, 2003
    Applicant: Penwest Pharmaceuticals Company
    Inventors: Anand R. Baichwal, Huai-Hung Kao, Troy W. McCall
  • Controlled release formulation (albuterol)
    Patent number: 5958456
    Abstract: A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional hydrophobic material and/or hydrophobic coating, and a medicament for sustained oral administration.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: September 28, 1999
    Assignee: Edward Mendell Co., Inc.
    Inventors: Anand Baichwal, Troy W. McCall
  • Controlled release formulation (albuterol)
    Patent number: 5662933
    Abstract: A sustained release pharmaceutical formulation and methods of making and using the same are provided. The sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional hydrophobic material and/or hydrophobic coating, and a medicament for sustained oral administration.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: September 2, 1997
    Assignee: Edward Mendell Co., Inc.
    Inventors: Anand Baichwal, Troy W. McCall
  • Once-a-day metoprolol oral dosage form
    Patent number: 5399362
    Abstract: A sustained release oral solid dosage form of metoprolol pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, a cationic cross-linking agent. The formulation provides release of metoprolol for at least about 24 hours.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: March 21, 1995
    Assignee: Edward Mendell Co., Inc.
    Inventors: Anand Baichwal, Troy W. McCall